Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

B. Pieske, C. Tschöpe, RA. de Boer, AG. Fraser, SD. Anker, E. Donal, F. Edelmann, M. Fu, M. Guazzi, CSP. Lam, P. Lancellotti, V. Melenovsky, DA. Morris, E. Nagel, E. Pieske-Kraigher, P. Ponikowski, SD. Solomon, RS. Vasan, FH. Rutten, AA. Voors,...

. 2019 ; 40 (40) : 3297-3317. [pub] 20191021

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028785

Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA-PEFF diagnostic algorithm'. Step 1 (P=Pre-test assessment) is typically performed in the ambulatory setting and includes assessment for HF symptoms and signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), and diagnostic laboratory tests, electrocardiogram, and echocardiography. In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least one typical risk factor. Elevated natriuretic peptides support, but normal levels do not exclude a diagnosis of HFpEF. The second step (E: Echocardiography and Natriuretic Peptide Score) requires comprehensive echocardiography and is typically performed by a cardiologist. Measures include mitral annular early diastolic velocity (e'), left ventricular (LV) filling pressure estimated using E/e', left atrial volume index, LV mass index, LV relative wall thickness, tricuspid regurgitation velocity, LV global longitudinal systolic strain, and serum natriuretic peptide levels. Major (2 points) and Minor (1 point) criteria were defined from these measures. A score ≥5 points implies definite HFpEF; ≤1 point makes HFpEF unlikely. An intermediate score (2-4 points) implies diagnostic uncertainty, in which case Step 3 (F1: Functional testing) is recommended with echocardiographic or invasive haemodynamic exercise stress tests. Step 4 (F2: Final aetiology) is recommended to establish a possible specific cause of HFpEF or alternative explanations. Further research is needed for a better classification of HFpEF.

Cardiology and CIC IT1414 CHU de Rennes LTSI Université Rennes 1 INSERM 1099 Rennes France

Cardiovascular Division Brigham and Women's Hospital Harvard Medical School Boston MA USA

Department of Biomedical Sciences for Health University of Milan IRCCS Milan Italy Department of Cardiology IRCCS Policlinico San Donato Milanese Milan Italy

Department of Cardiology Heart Valve Clinic University of Liège Hospital GIGA Cardiovascular Sciences CHU Sart Tilman Liège Belgium

Department of Cardiology National and Kapodistrian University of Athens Medical School

Department of Internal Medicine and Cardiology Charité Universitätsmedizin Berlin Campus Virchow Klinikum

Department of Internal Medicine and Cardiology Charité Universitätsmedizin Berlin Campus Virchow Klinikum German Center for Cardiovascular Research Berlin Partner Site Germany

Department of Internal Medicine and Cardiology Charité Universitätsmedizin Berlin Campus Virchow Klinikum German Center for Cardiovascular Research Charite Berlin Germany

Department of Internal Medicine and Cardiology Charité Universitätsmedizin Berlin Campus Virchow Klinikum German Center for Cardiovascular Research Germany

Department of Physiology and Amsterdam Cardiovascular Sciences Amsterdam University Medical Center The Netherlands

Institute for Clinical and Experimental Medicine IKEM Prague Czech Republic

Institute for Experimental and Translational Cardiovascular Imaging University Hospital Frankfurt German Centre for Cardiovascular Research Partner Site Frankfurt Germany

Julius Center for Health Sciences and Primary Care University Medical Center Utrecht Utrecht University Utrecht The Netherlands

Medical University Clinical Military Hospital Wroclaw Poland

National Heart Centre Singapore and Duke National University of Singapore University Medical Centre Groningen The Netherlands

School of Medicine Cardiff University Cardiff UK

Section of Cardiology Department of Medicine Sahlgrenska University Hosptal Ostra Göteborg Sweden

Section of Preventive Medicine and Epidemiology and Cardiovascular Medicine Department of Medicine Boston University School of Medicine Boston MA USA

University Heart Centre University Hospital Zurich Switzerland

University Hospital Attikon Athens Greece University of Cyprus School of Medicine Nicosia Cyprus

University Medical Centre Groningen University of Groningen Department of Cardiology Groningen the Netherlands

University of Belgrade School of Medicine Belgrade University Medical Center Serbia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028785
003      
CZ-PrNML
005      
20230201085343.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurheartj/ehz641 $2 doi
035    __
$a (PubMed)31504452
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pieske, Burkert $u Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. German Center for Cardiovascular Research (DZHK), Berlin, Partner Site, Germany. Department of Internal Medicine and Cardiology, German Heart Institute, Berlin, Germany. Berlin Institute of Health (BIH), Germany.
245    10
$a How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) / $c B. Pieske, C. Tschöpe, RA. de Boer, AG. Fraser, SD. Anker, E. Donal, F. Edelmann, M. Fu, M. Guazzi, CSP. Lam, P. Lancellotti, V. Melenovsky, DA. Morris, E. Nagel, E. Pieske-Kraigher, P. Ponikowski, SD. Solomon, RS. Vasan, FH. Rutten, AA. Voors, F. Ruschitzka, WJ. Paulus, P. Seferovic, G. Filippatos,
520    9_
$a Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA-PEFF diagnostic algorithm'. Step 1 (P=Pre-test assessment) is typically performed in the ambulatory setting and includes assessment for HF symptoms and signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), and diagnostic laboratory tests, electrocardiogram, and echocardiography. In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least one typical risk factor. Elevated natriuretic peptides support, but normal levels do not exclude a diagnosis of HFpEF. The second step (E: Echocardiography and Natriuretic Peptide Score) requires comprehensive echocardiography and is typically performed by a cardiologist. Measures include mitral annular early diastolic velocity (e'), left ventricular (LV) filling pressure estimated using E/e', left atrial volume index, LV mass index, LV relative wall thickness, tricuspid regurgitation velocity, LV global longitudinal systolic strain, and serum natriuretic peptide levels. Major (2 points) and Minor (1 point) criteria were defined from these measures. A score ≥5 points implies definite HFpEF; ≤1 point makes HFpEF unlikely. An intermediate score (2-4 points) implies diagnostic uncertainty, in which case Step 3 (F1: Functional testing) is recommended with echocardiographic or invasive haemodynamic exercise stress tests. Step 4 (F2: Final aetiology) is recommended to establish a possible specific cause of HFpEF or alternative explanations. Further research is needed for a better classification of HFpEF.
650    _2
$a senioři $7 D000368
650    12
$a algoritmy $7 D000465
650    _2
$a kardiologie $x organizace a řízení $7 D002309
650    12
$a klinické rozhodování $7 D000066491
650    _2
$a konsensus $7 D032921
650    _2
$a echokardiografie $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a diastolické srdeční selhání $x diagnóza $x etiologie $x patofyziologie $7 D054144
650    _2
$a srdeční komory $x diagnostické zobrazování $x patofyziologie $7 D006352
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a natriuretické peptidy $x krev $7 D045265
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tschöpe, Carsten $u Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. German Center for Cardiovascular Research (DZHK), Berlin, Partner Site, Germany. Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT), Charite, Berlin, Germany.
700    1_
$a de Boer, Rudolf A $u University Medical Centre Groningen, University of Groningen, Department of Cardiology, Groningen, the Netherlands.
700    1_
$a Fraser, Alan G $u School of Medicine, Cardiff University, Cardiff, UK.
700    1_
$a Anker, Stefan D $u Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. German Center for Cardiovascular Research (DZHK), Berlin, Partner Site, Germany. Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT), Charite, Berlin, Germany. Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Germany.
700    1_
$a Donal, Erwan $u Cardiology and CIC, IT1414, CHU de Rennes LTSI, Université Rennes-1, INSERM 1099, Rennes, France.
700    1_
$a Edelmann, Frank $u Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum. German Center for Cardiovascular Research (DZHK), Berlin, Partner Site, Germany.
700    1_
$a Fu, Michael $u Section of Cardiology, Department of Medicine, Sahlgrenska University Hosptal/Ostra, Göteborg, Sweden.
700    1_
$a Guazzi, Marco $u Department of Biomedical Sciences for Health, University of Milan, IRCCS, Milan, Italy. Department of Cardiology, IRCCS Policlinico, San Donato Milanese, Milan, Italy.
700    1_
$a Lam, Carolyn S P $u National Heart Centre, Singapore & Duke-National University of Singapore. University Medical Centre Groningen, The Netherlands.
700    1_
$a Lancellotti, Patrizio $u Department of Cardiology, Heart Valve Clinic, University of Liège Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, Liège, Belgium.
700    1_
$a Melenovsky, Vojtech $u Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic.
700    1_
$a Morris, Daniel A $u Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum.
700    1_
$a Nagel, Eike $u Institute for Experimental and Translational Cardiovascular Imaging, University Hospital Frankfurt. German Centre for Cardiovascular Research (DZHK), Partner Site Frankfurt, Germany.
700    1_
$a Pieske-Kraigher, Elisabeth $u Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum.
700    1_
$a Ponikowski, Piotr $u Medical University, Clinical Military Hospital, Wroclaw, Poland.
700    1_
$a Solomon, Scott D $u Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
700    1_
$a Vasan, Ramachandran S $u Section of Preventive Medicine and Epidemiology and Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
700    1_
$a Rutten, Frans H $u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
700    1_
$a Voors, Adriaan A $u University Medical Centre Groningen, University of Groningen, Department of Cardiology, Groningen, the Netherlands.
700    1_
$a Ruschitzka, Frank $u University Heart Centre, University Hospital Zurich, Switzerland.
700    1_
$a Paulus, Walter J., $u Department of Physiology and Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, The Netherlands. $d 1952- $7 xx0281492
700    1_
$a Seferovic, Petar $u University of Belgrade School of Medicine, Belgrade University Medical Center, Serbia.
700    1_
$a Filippatos, Gerasimos $u Department of Cardiology, National and Kapodistrian University of Athens Medical School; University Hospital "Attikon", Athens, Greece. University of Cyprus, School of Medicine, Nicosia, Cyprus.
773    0_
$w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 40, č. 40 (2019), s. 3297-3317
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31504452 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20230201085338 $b ABA008
999    __
$a ok $b bmc $g 1609120 $s 1119965
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 40 $c 40 $d 3297-3317 $e 20191021 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...